Skip to main content

Juan Espinosa Pereiro

Juan Espinosa Pereiro, graduated in Medicine from the University of Santiago de Compostela. Specialist in Internal Medicine and Infectious Diseases at the H. U. Vall d'Hebrón, in Barcelona. He is a researcher and clinical member of the International Health Program of the Catalan Institute of Health. Collaborating researcher in the EUSAT-RCS and EU-PEARL projects. He also participates in several competitive projects within the national scope. Member of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), and within them their respective mycobacteria study groups (GEIM and ESGMYC, respectively). He has participated in the publication of several scientific articles in the field of Infectious Diseases, including tuberculosis, Chagas disease and COVID-19.

Institutions of which they are part

Predoctoral researcher
Infectious Diseases
Vall Hebron Institut de Recerca
Accident and Emergency Department
General Hospital
Doctor
Infectious Diseases
Cross-departmental services

Juan Espinosa Pereiro

Institutions of which they are part

Predoctoral researcher
Infectious Diseases
Vall Hebron Institut de Recerca
Accident and Emergency Department
General Hospital
Doctor
Infectious Diseases
Cross-departmental services

Juan Espinosa Pereiro, graduated in Medicine from the University of Santiago de Compostela. Specialist in Internal Medicine and Infectious Diseases at the H. U. Vall d'Hebrón, in Barcelona. He is a researcher and clinical member of the International Health Program of the Catalan Institute of Health. Collaborating researcher in the EUSAT-RCS and EU-PEARL projects. He also participates in several competitive projects within the national scope. Member of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), and within them their respective mycobacteria study groups (GEIM and ESGMYC, respectively). He has participated in the publication of several scientific articles in the field of Infectious Diseases, including tuberculosis, Chagas disease and COVID-19.

EDUCATION
2007-2013: Degree with Extraordinary Award in Medicine. Universidade de Santiago de Compostela.
PhD candidate: “Mycobacterium tuberculosis resistance to and optimization of first line drugs.” October 2019 to present: Universitat Autónoma de Barcelona, Barcelona, Cataluña, Spain. Director: Adrián Sánchez-Montalvá.
Residence May 2014 -May 2019: Internal Medicine. Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, Cataluña, Spain.
Subspecialization May 2017 to May 2019: Infectious Diseases. Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, Cataluña, Spain.
Internships November-December 2018: Tropical Diseases Oxford University Clinical Research Unit Vietnam, Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam.
October-December 2019 and June-July 2022: Tuberculosis Instituto de Enfermedades Respiratorias y del Ambiente (INERAM), Asunción, Paraguay. Programa Nacional de Control de la Tuberculosis (PNCT), Asunción Paraguay.

PROFESSIONAL EXPERIENCE
Licensed Physician number 50420, in Barcelona, 2014.
May 2019 to present: Emergency Department, attending physician.
May 2019 to present: Global Health and Tropical Diseases.

RESEARCH EXPERIENCE
Competitive grants participation:
November 2019 to present: Pre-doctoral Research Fellow at EU Patient-cEntric clinical tRial pLatform (EU-PEARL). Grant number 853966.
May 2019 to present: Pre-doctoral Research Fellow at European-Latin American TB Research Collaboration Network (EUSAT-RCS). Grant number: 823890.
Good clinical practice certificate: until April 23rd 2023.

PUBLICATIONS
First-author:
A restrospective study on the influence of sibling’s relatedness in Bolivian patients with
chronic Chagas disease. Parasites and Vectors. 2019 12:260
MDR Tuberculosis Treatment. Medicina (Kaunas). 2022 Jan 26;58(2):188. doi: 10.3390/medicina58020188.

Co-authored:
Ulcers on psoriatic plaques in a patient with advanced Human Immunodeficiency Virus infection. Enfermedades Infecciosas y Microbiología clínica, 2017 Nov;35(9):605-606. PMID 27240445.
Mixed connective tissue disease and epitope spreading: An Historical Cohort Study. Journal of Clinical Rheumatology. 2017 Apr;23(3): 155-159. PMID 28248800.
Usefulness of FDG PET/CT in the management of tuberculosis. PLoS ONE. 2019 14 (8): e0221516
Tigecycline-associated hypofibrinogenemia in a real-world setting. International Journal of Clinical Pharmacology. 2020 Aug;42(4):1184-1189. PMID: 32504166.
Blastocystis sp. carriage and irritable bowel syndrome: is the association already established? Biology. 2021, 10, 340.
Risk of SARS-COV-2 infection in previously infected and non-infected cohorts of health workers at high risk of exposure. Journal of Clinical Medicine. 2021 April, 10, 1968.
Early outcomes in adults hospitalized with severe SARS-CoV-2 infection receiving tocilizumab. Medicina Clinica. 2021 Jun 18:S0025-7753(21)00360-2. PMID: 34544604.
Impact of the COVID-19 pandemic on tuberculosis management in Spain. International Journal of Infectious Diseases. 2021 Jul;108:300-305. PMID: 33930543. Imported cystic echinococcosis in Spain: a systematic review. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2021 Oct 1;115(10):1184-1189. PMID: 33631003.

Other publications
Guía práctica de actuación en epidemias de COVID-19 en residencias para personas mayores. [Practical actuation guideline for COVID-19 epidemics in nursing facilities]. Sociedad Española de Medicina de Familia y Comunitaria. Enero 2021.

Projects

Estrategias de optimización del tratamiento de la tuberculosis pulmonar

IP: Israel Molina Romero
Collaborators: Juan Espinosa Pereiro, Laia Perez Lasarte
Funding agency: Instituto de Salud Carlos III
Funding: 65000
Reference: CM22/00246
Duration: 31/03/2023 - 31/03/2024

Malalties infeccioses

IP: Vicenç Falcó Ferrer
Collaborators: Jose Santos Santiago, Maria Luisa Aznar Ruiz de Alegria, Adria Curran Fàbregas, Jorge Nestor Garcia Perez, Oscar Len Abad, Mª Carmen Ferrer Barberà, Javier Gomis Rodriguez, Diana Pou Ciruelo, Begoña Treviño Maruri, Nuria Fernández Hidalgo, Joan Gavaldà Santapau, Juan Espinosa Pereiro, Bibiana Planas Ribas, Ma Dolores Rodríguez Pardo, Pau Bosch Nicolau, David Perea Pérez, Israel Molina Romero, Patricia Álvarez López, Luis Lopez Perez, Vicente Descalzo Jorro, Marta Sanchiz Cruz, Nuria Serre Delcor, Laura Escola Verge, Julia Sellares Nadal, Fernando M Salvador Velez, Isabel Ruiz Camps, Estela Muñoz Castarlenas, Marta Palau Gauthier, Jordi Gómez i Prat, María José Buzón Gómez, Hakima Ouaarab Essadek, Paula Suanzes Diez, Jordi Navarro Mercadé, Esperanza Esteban Serna, Raisa Morales Martinez, Joaquin Burgos Cibrian, Nerea Sanchez Gaona, Joan Rey Cano, Adrián Sánchez Montalvá, Cristina Mancebo Perez, Montserrat Llinás Vidal, Sebastian Gonzalez Kuguel, Ana Gallego Cortes, Maider Arando Lasagabaster, Ibai Los Arcos Bertiz, Claudia Broto Cortes, Ester Marquez Algaba, Benito Almirante Gragera, Desideria Martinez Rascón, Lucia Rodriguez Vazquez, Meritxell Genesca Ferrer, Ines Mercedes Oliveira Souto, Silvina Andrea Magnani , Yasmine Margaret Baktash , Daniël Kees Johan Pieren
Funding agency: AGAUR no fer servir-correcte 4301-37
Funding: 60000
Reference: 2021 SGR 00764
Duration: 01/01/2022 - 31/12/2024

EU Patient- cEntric clinicAl tRial pLatform - EU PEARL.

IP: Joan Genescà Ferrer
Collaborators: Santiago Pérez Hoyos, Anna Sanjuan Viaplana, Marta Fatima Valverde Collazo, Sarai Rodríguez Navarro, Xavier Cañas Perea, Juan Espinosa Pereiro, Juan Manuel Pericàs Pulido, José Antonio Ramos Quiroga, Israel Molina Romero, Alex Sánchez Pla, Inmaculada Fuentes Camps, Elena de Sena Fernández, Esther Arevalo Andres, Susana Graciela Kalko Witruk, Adrián Sánchez Montalvá, Pol Ibañez Jimenez, Olga Sánchez- Maroto Carrizo, Gara Arteaga Henriquez, Jesus Manuel Rivera Esteban, Gabriela Perez Fuentes Ruiz, Maria Fernanda Barroso de Sousa, Sandra Aixut Mayordomo, Sergio Gabriel Muñoz Martínez, Clara Navarro Villarreal, Janna Anthonina Slabbekoorn , Albert Barberà LLuis
Funding agency: The Innovative Medicines Initiative
Funding: 1987375
Reference: EU-PEARL_H2020_IMI2-2018
Duration: 01/11/2019 - 30/04/2023

European-Latin American TB Research Collaboration Network

IP: Adrián Sánchez Montalvá
Collaborators: Maria Luisa Aznar Ruiz de Alegria, Juan Espinosa Pereiro
Funding agency: EUROPEAN COMMISSION
Funding: 172200
Reference: EUSAT-RCS_H2020MSCA-RISE2018
Duration: 04/04/2019 - 31/03/2024

Related news

The study shows that blocking the KLRG1 receptor helps to recover the activity of the natural killer cells of the immune system and reactivate the virus reservoir to fight infection.

This new method improves and streamlines drug development processes

Members of the Infectious Diseases research group and the VHIR Management participated in the sessions and visited the areas where the CRESCER and FUTURO projects are developed.

Related professionals

Gemma Galán Martinez

Gemma Galán Martinez

P Management and Admin. Project manager
Strategic Projects Unit
Competitive Projects Area
Read more
Samar Zaher Zatara

Samar Zaher Zatara

Research technician
Research Group of Physical Medicine and Rehabilitation
Read more
Imane Boutitah Benyaich

Imane Boutitah Benyaich

Predoctoral researcher
Clinical Neuroimmunology
Read more
Helena Bartra Serrano

Helena Bartra Serrano

P Management and Admin. Project manager
Strategic Projects Unit
Competitive Projects Area
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.